Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 183

    1.

    Genetic Association and Interaction Analysis of USF1 and APOA5 on Lipid Levels and Atherosclerosis.

    Laurila PP, Naukkarinen J, Kristiansson K, Ripatti S, Kauttu T, Silander K, Salomaa V, Perola M, Karhunen PJ, Barter PJ, Ehnholm C, Peltonen L.

    Arterioscler Thromb Vasc Biol. 2009 Nov 12. [Epub ahead of print]PMID: 19910639 [PubMed - as supplied by publisher]Related articles

    2.

    Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts.

    Peshavariya H, Dusting GJ, Di Bartolo B, Rye KA, Barter PJ, Jiang F.

    Free Radic Res. 2009 Jun 10:1-11. [Epub ahead of print]PMID: 19521892 [PubMed - as supplied by publisher]Related articles

    3.

    Cholesterol metabolism and pancreatic beta-cell function.

    Fryirs M, Barter PJ, Rye KA.

    Curr Opin Lipidol. 2009 Jun;20(3):159-64. Review.PMID: 19417651 [PubMed - indexed for MEDLINE]Related articles

    4.

    Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells.

    McGrath KC, Li XH, Puranik R, Liong EC, Tan JT, Dy VM, DiBartolo BA, Barter PJ, Rye KA, Heather AK.

    Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):877-82. Epub 2009 Mar 26.PMID: 19325144 [PubMed - indexed for MEDLINE]Related articles

    5.

    Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.

    Taskinen MR, Sullivan DR, Ehnholm C, Whiting M, Zannino D, Simes RJ, Keech AC, Barter PJ; FIELD study investigators.

    Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):950-5. Epub 2009 Mar 26.PMID: 19325138 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

    Patel S, Drew BG, Nakhla S, Duffy SJ, Murphy AJ, Barter PJ, Rye KA, Chin-Dusting J, Hoang A, Sviridov D, Celermajer DS, Kingwell BA.

    J Am Coll Cardiol. 2009 Mar 17;53(11):962-71.PMID: 19281927 [PubMed - indexed for MEDLINE]Related articles

    7.

    Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study.

    Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Cohen JC, Grundy SM, Mooser VE, Mitchell BD.

    Obesity (Silver Spring). 2009 Apr;17(4):737-44. Epub 2009 Jan 22.PMID: 19165155 [PubMed - indexed for MEDLINE]Related articles

    8.

    Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins.

    Patel S, Puranik R, Nakhla S, Lundman P, Stocker R, Wang XS, Lambert G, Rye KA, Barter PJ, Nicholls SJ, Celermajer DS.

    Atherosclerosis. 2009 Jun;204(2):424-8. Epub 2008 Nov 21.PMID: 19111829 [PubMed - indexed for MEDLINE]Related articles

    9.

    The metabolism and anti-atherogenic properties of HDL.

    Rye KA, Bursill CA, Lambert G, Tabet F, Barter PJ.

    J Lipid Res. 2009 Apr;50 Suppl:S195-200. Epub 2008 Nov 24. Review.PMID: 19033213 [PubMed - indexed for MEDLINE]Related articles

    10.

    Antiinflammatory actions of HDL: a new insight.

    Rye KA, Barter PJ.

    Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1890-1. No abstract available. PMID: 18946054 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.

    Nobécourt E, Zeng J, Davies MJ, Brown BE, Yadav S, Barter PJ, Rye KA.

    Diabetologia. 2008 Jun;51(6):1008-17. Epub 2008 Apr 24.PMID: 18437350 [PubMed - indexed for MEDLINE]Related articles

    12.

    Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment.

    Lambert G, Ancellin N, Charlton F, Comas D, Pilot J, Keech A, Patel S, Sullivan DR, Cohn JS, Rye KA, Barter PJ.

    Clin Chem. 2008 Jun;54(6):1038-45. Epub 2008 Apr 24.PMID: 18436719 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.

    Barter PJ, Puranik R, Rye KA.

    Curr Cardiol Rep. 2007 Nov;9(6):493-8. Review.PMID: 17999875 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of torcetrapib in patients at high risk for coronary events.

    Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B; ILLUMINATE Investigators.

    N Engl J Med. 2007 Nov 22;357(21):2109-22. Epub 2007 Nov 5.PMID: 17984165 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.

    Settasatian N, Barter PJ, Rye KA.

    J Lipid Res. 2008 Jan;49(1):115-26. Epub 2007 Oct 5.PMID: 17921435 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa.

    Homer VM, Marais AD, Charlton F, Laurie AD, Hurndell N, Scott R, Mangili F, Sullivan DR, Barter PJ, Rye KA, George PM, Lambert G.

    Atherosclerosis. 2008 Feb;196(2):659-66. Epub 2007 Aug 31.PMID: 17765244 [PubMed - indexed for MEDLINE]Related articles

    17.

    Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?

    Barter PJ, Rye KA.

    Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):39-46. Epub 2007 Aug 23. Review.PMID: 17717290 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo.

    Puranik R, Bao S, Nobecourt E, Nicholls SJ, Dusting GJ, Barter PJ, Celermajer DS, Rye KA.

    Atherosclerosis. 2008 Jan;196(1):240-7. Epub 2007 Jun 27.PMID: 17586510 [PubMed - indexed for MEDLINE]Related articles

    19.

    N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins.

    Skropeta D, Settasatian C, McMahon MR, Shearston K, Caiazza D, McGrath KC, Jin W, Rader DJ, Barter PJ, Rye KA.

    J Lipid Res. 2007 Sep;48(9):2047-57. Epub 2007 Jun 3.PMID: 17545692 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Aggressive management of obesity in children and young adults: the known challenges and potential opportunities.

    Barter PJ, Shear CL.

    Clin Pharmacol Ther. 2007 May;81(5):627-30.PMID: 17438536 [PubMed - indexed for MEDLINE]Related articles

    21.

    Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.

    Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE 1 Investigators.

    N Engl J Med. 2007 Apr 19;356(16):1620-30. Epub 2007 Mar 26.PMID: 17387131 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.

    Nobecourt E, Davies MJ, Brown BE, Curtiss LK, Bonnet DJ, Charlton F, Januszewski AS, Jenkins AJ, Barter PJ, Rye KA.

    Diabetologia. 2007 Mar;50(3):643-53. Epub 2007 Jan 10.PMID: 17216278 [PubMed - indexed for MEDLINE]Related articles

    23.

    Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.

    Barter PJ, Rye KA.

    Circulation. 2006 Sep 19;114(12):1315-20; discussion 1320. No abstract available. PMID: 16982953 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Homocysteine and cardiovascular disease: is HDL the link?

    Barter PJ, Rye KA.

    Circ Res. 2006 Sep 15;99(6):565-6. Review. No abstract available. PMID: 16973911 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function.

    Nicholls SJ, Lundman P, Harmer JA, Cutri B, Griffiths KA, Rye KA, Barter PJ, Celermajer DS.

    J Am Coll Cardiol. 2006 Aug 15;48(4):715-20. Epub 2006 Jul 24.PMID: 16904539 [PubMed - indexed for MEDLINE]Related articles

    26.

    Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.

    Barter PJ, Rye KA.

    Curr Opin Lipidol. 2006 Aug;17(4):399-403. Review.PMID: 16832163 [PubMed - indexed for MEDLINE]Related articles

    27.

    The rationale for using apoA-I as a clinical marker of cardiovascular risk.

    Barter PJ, Rye KA.

    J Intern Med. 2006 May;259(5):447-54. Review.PMID: 16629850 [PubMed - indexed for MEDLINE]Related articles

    28.

    Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?

    Barter PJ, Rye KA.

    Circulation. 2006 Mar 28;113(12):1553-5. Review. No abstract available. PMID: 16567579 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    High-density lipoproteins enhance progenitor-mediated endothelium repair in mice.

    Tso C, Martinic G, Fan WH, Rogers C, Rye KA, Barter PJ.

    Arterioscler Thromb Vasc Biol. 2006 May;26(5):1144-9. Epub 2006 Mar 9.PMID: 16528007 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

    Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM.

    J Intern Med. 2006 Mar;259(3):247-58.PMID: 16476102 [PubMed - indexed for MEDLINE]Related articles

    31.

    Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.

    Barter PJ, Kastelein JJ.

    J Am Coll Cardiol. 2006 Feb 7;47(3):492-9. Epub 2006 Jan 18. Review.PMID: 16458126 [PubMed - indexed for MEDLINE]Related articles

    32.

    Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.

    Rye KA, Bright R, Psaltis M, Barter PJ.

    J Lipid Res. 2006 May;47(5):1025-36. Epub 2006 Feb 1.PMID: 16452453 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits.

    Kee P, Caiazza D, Rye KA, Barrett PH, Morehouse LA, Barter PJ.

    Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):884-90. Epub 2005 Dec 22.PMID: 16373610 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit.

    Hime NJ, Drew KJ, Wee K, Barter PJ, Rye KA.

    J Lipid Res. 2006 Jan;47(1):115-22. Epub 2005 Oct 12.PMID: 16222033 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.

    Nicholls SJ, Cutri B, Worthley SG, Kee P, Rye KA, Bao S, Barter PJ.

    Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2416-21. Epub 2005 Sep 1.PMID: 16141405 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.

    Yu Y, Wyszynski DF, Waterworth DM, Wilton SD, Barter PJ, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Ma Q, Sharma SS, Montgomery DS, Middleton LT, Sundseth SS, Mooser V, Grundy SM, Farrer LA.

    J Lipid Res. 2005 Oct;46(10):2202-13. Epub 2005 Aug 1.PMID: 16061952 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Cardioprotective effects of high-density lipoproteins: the evidence strengthens.

    Barter PJ.

    Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1305-6. No abstract available. PMID: 15980266 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Antiatherogenic properties of fibrates.

    Barter PJ.

    Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1095-6. No abstract available. PMID: 15923541 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    High-density lipoproteins as therapeutic targets.

    Nicholls SJ, Rye KA, Barter PJ.

    Curr Opin Lipidol. 2005 Jun;16(3):345-9. Review.PMID: 15891397 [PubMed - indexed for MEDLINE]Related articles

    40.

    Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits.

    Nicholls SJ, Dusting GJ, Cutri B, Bao S, Drummond GR, Rye KA, Barter PJ.

    Circulation. 2005 Mar 29;111(12):1543-50. Epub 2005 Mar 21.PMID: 15781735 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).

    Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM.

    Am J Cardiol. 2005 Jan 15;95(2):194-8.PMID: 15642551 [PubMed - indexed for MEDLINE]Related articles

    42.

    Antiinflammatory properties of HDL.

    Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM.

    Circ Res. 2004 Oct 15;95(8):764-72. Review.PMID: 15486323 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner.

    Hime NJ, Drew KJ, Hahn C, Barter PJ, Rye KA.

    Biochemistry. 2004 Sep 28;43(38):12306-14.PMID: 15379569 [PubMed - indexed for MEDLINE]Related articles

    44.

    High-density lipoproteins neutralize C-reactive protein proinflammatory activity.

    Wadham C, Albanese N, Roberts J, Wang L, Bagley CJ, Gamble JR, Rye KA, Barter PJ, Vadas MA, Xia P.

    Circulation. 2004 May 4;109(17):2116-22. Epub 2004 Apr 12.PMID: 15078800 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.

    Schuster H, Barter PJ, Stender S, Cheung RC, Bonnet J, Morrell JM, Watkins C, Kallend D, Raza A; Effective Reductions in Cholesterol Using Rosuvastatin Therapy I study group.

    Am Heart J. 2004 Apr;147(4):705-13.PMID: 15077101 [PubMed - indexed for MEDLINE]Related articles

    46.

    Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids.

    Duong M, Psaltis M, Rader DJ, Marchadier D, Barter PJ, Rye KA.

    Biochemistry. 2003 Nov 25;42(46):13778-85.PMID: 14622025 [PubMed - indexed for MEDLINE]Related articles

    47.

    Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.

    Rye KA, Barter PJ.

    Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):421-8. Epub 2003 Oct 30. Review.PMID: 14592845 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Investigation of pond velocities using dye and small drogues: a case study of the Nelson City waste stabilisation pond.

    Barter PJ.

    Water Sci Technol. 2003;48(2):145-51.PMID: 14510205 [PubMed - indexed for MEDLINE]Related articles

    49.

    Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.

    Rye KA, Wee K, Curtiss LK, Bonnet DJ, Barter PJ.

    J Biol Chem. 2003 Jun 20;278(25):22530-6. Epub 2003 Apr 10.PMID: 12690114 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.

    Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR.

    Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):160-7. Review.PMID: 12588754 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...